SEC Form 4 · accession 0001562180-18-003282
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard E Kaufman
Officer — Sr VP& Chief Operating Officer
Period of report
Jul 10, 2018
Accepted (ET)
Jul 12, 2018 · 7:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2018 | M | 7,000 | $13.05 | A | 94,512 | D | |
| Common StockF2 | Jul 10, 2018 | S | 7,000 | $35.018 | D | 87,512 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $13.05 | Jul 10, 2018 | M | 7,000 | D | — | Jan 17, 2027 | Common Stock | 7,000 | 35,000 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2018.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.90 to $35.50, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F3The vesting commencement date of the option is January 1, 2017. 1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.